fda warning bpc-157 unapproved peptide risks new drug The FDA has issued clear signals on BPC-157 Five reasons adding peptides to
Description
10.2174/1381612824666180712110447 101 SeiwerthS.SikiricP.GrabarevicZ.ZoricicI.HanzevackiM.LjubanovicD.et al (1997)

Repeated missed doses will impact results, so establish systems to ensure consistency

Always label the vial with the date of reconstitution and the final concentration

doi: 10.1164/ajrccm.158.1.9712053
